The combination of BD-9136 and gemcitabine also suppressed the in vitro growth of a mouse oncogenic KRAS (KPC) PDAC cell line as well as pancreatic orthotopic tumor growth (Figure 7, E and G, and Supplemental Figure 9E). This evidence concerns the gene KRAS and neoplasm.